| Literature DB >> 31308541 |
Antigoni Morou1,2, Elsa Brunet-Ratnasingham1,2, Mathieu Dubé1,3, Roxanne Charlebois1, Eloi Mercier4, Sam Darko5, Nathalie Brassard1, Krystelle Nganou-Makamdop5, Sahaana Arumugam5, Gabrielle Gendron-Lepage1,2, Lifei Yang6, Julia Niessl1,2,3, Amy E Baxter1,2,3,7, James M Billingsley8, Premeela A Rajakumar8, François Lefebvre4, R Paul Johnson8, Cécile Tremblay1,2, Jean-Pierre Routy9, Richard T Wyatt3,6, Andrés Finzi1,2, Daniel C Douek5, Daniel E Kaufmann10,11,12.
Abstract
Dysfunction of virus-specific CD4+ T cells in chronic human infections is poorly understood. We performed genome-wide transcriptional analyses and functional assays of CD4+ T cells specific for human immunodeficiency virus (HIV) from HIV-infected people before and after initiation of antiretroviral therapy (ART). A follicular helper T cell (TFH cell)-like profile characterized HIV-specific CD4+ T cells in viremic infection. HIV-specific CD4+ T cells from people spontaneously controlling the virus (elite controllers) robustly expressed genes associated with the TH1, TH17 and TH22 subsets of helper T cells. Viral suppression by ART resulted in a distinct transcriptional landscape, with a reduction in the expression of genes associated with TFH cells, but persistently low expression of genes associated with TH1, TH17 and TH22 cells compared to the elite controller profile. Thus, altered differentiation is central to the impairment of HIV-specific CD4+ T cells and involves both gain of function and loss of function.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31308541 PMCID: PMC6642691 DOI: 10.1038/s41590-019-0418-x
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606